MQS Management’s AstraZeneca AZN Stock Holding History

MQS Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,428	Closed	-$219K	–	416
2025 Q3	$219K	Sell	1,428 -1,270	-47%	-$192K	0.13%	352
2025 Q2	$377K	Sell	2,698 -176	-6%	-$24.7K	0.21%	206
2025 Q1	$422K	Buy	+2,874	New	+$416K	0.24%	171
2024 Q4	–	Sell	-5,341	Closed	-$832K	–	63
2024 Q3	$832K	Buy	5,341 +4,017	+303%	+$648K	0.46%	34
2024 Q2	$207K	Sell	1,324 -2,668	-67%	-$401K	0.12%	353
2024 Q1	$541K	Buy	+3,992	New	+$529K	0.31%	105
2023 Q4	–	Sell	-4,245	Closed	-$575K	–	460
2023 Q3	$575K	Buy	4,245 +1,664	+64%	+$227K	0.35%	72
2023 Q2	$369K	Buy	+2,581	New	+$380K	0.25%	152
2022 Q4	–	Sell	-5,468	Closed	-$600K	–	382
2022 Q3	$600K	Buy	5,468 +3,846	+237%	+$488K	0.39%	64
2022 Q2	$214K	Buy	+1,622	New	+$213K	0.15%	308
2022 Q1	–	Sell	-2,990	Closed	-$348K	–	340
2021 Q4	$348K	Buy	+2,990	New	+$352K	0.56%	64

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MQS Management's AZN Position: Q4 2025 in Review

MQS Management sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 1,428 shares — an estimated $219K sold.

MQS Management first reported a position in AZN in Q4 2021 and held it in 11 quarters. The position peaked at $832K in Q3 2024. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

MQS Management reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
MQS Management sold 1,428 AstraZeneca shares in Q4 2025, an estimated $219K.
MQS Management first reported a position in AstraZeneca in Q4 2021 and held it in 11 quarters.
MQS Management's AstraZeneca position peaked at $832K in Q3 2024.
1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on MQS Management's 13F filing for Q4 2025, filed 9 Feb 2026.